These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16990957)

  • 21. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic low-grade inflammation and risk of coronary heart disease: results from the MONICA/KORA Augsburg cohort studies.
    Koenig W; Meisinger C; Baumert J; Khuseyinova N; Löwel H
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S62-7. PubMed ID: 16032519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L; Zhao SP; Hu M; Li JX
    Coron Artery Dis; 2007 Sep; 18(6):489-93. PubMed ID: 17700222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High sensivity C-reactive protein as a complement to classical methods in the evaluation of coronary event's risk].
    Markuszewski L; Pietruszyński R; Wojdyn M; Retelewska W
    Pol Merkur Lekarski; 2006 Apr; 20(118):448-52. PubMed ID: 16886574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of homocysteine concentration in coronary heart disease patients and comparison of two determination methods.
    Doncheva N; Penkov A; Velcheva A; Boev M; Popov B; Niagolov Y
    Ann Nutr Metab; 2007; 51(1):82-7. PubMed ID: 17356259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein and echocardiography have little impact on risk stratification in never-treated hypertensive patients.
    Conen D; Zeller A; Dieterle T; Martina B
    J Hum Hypertens; 2006 Aug; 20(8):587-92. PubMed ID: 16710289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
    Lee CT; Tsai YC; Ng HY; Su Y; Lee WC; Lee LC; Chiou TT; Liao SC; Hsu KT
    J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
    Ridker PM
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1222-4. PubMed ID: 18565847
    [No Abstract]   [Full Text] [Related]  

  • 34. Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease.
    Rasouli M; Kiasari AM; Bagheri B
    Clin Chim Acta; 2007 Feb; 377(1-2):127-32. PubMed ID: 17067564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Listening to the heart-brain talk: persistent depressive symptoms are associated with hsCRP in apparently healthy individuals at high risk for coronary artery disease.
    Azar R; Nolan RP; Stewart DE
    Eur J Prev Cardiol; 2012 Aug; 19(4):857-63. PubMed ID: 21729973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of arteriosclerosis using high sensitive CRP in multiphasic screening].
    Tonari Y; Koyama T; Saitoh K
    Rinsho Byori; 2004 Aug; 52(8):637-41. PubMed ID: 15478618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency Department education improves patient knowledge of coronary artery disease risk factors but not the accuracy of their own risk perception.
    Williams A; Lindsell C; Rue L; Blomkalns A
    Prev Med; 2007 Jun; 44(6):520-5. PubMed ID: 17336373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
    Zhou WD; Yang YL; Che ZH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.